Launched in September 2017, the Helium Alpha fund relies on a quantitative equity long/short hybrid strategy, also called Quantamental which combines quantitative and fundamental portfolio management approaches.
Invested in Europe, Helium Alpha is an absolute performance fund moderately correlated with the equity markets.
session | 3 years | 5 years | 10 years | Launch | |
---|---|---|---|---|---|
Accumulated Performance | 2.3% | 5.3% | 9.2% | - | 6.9% |
Annualized Performance | 2.2% | 1.7% | 1.8% | - | 0.9% |
% positive months | 58.3% | 50% | 51.7% | - | 52.9% |
Perf. Monthly Average | 0.3% | 0.2% | 0.2% | - | 0.1% |
Annualized Volatility | 3.7% | 4.7% | 5.5% | - | 5.7% |
Sharpe Ratio | -0.4 | -0.1 | 0.1 | - | 0.1 |
Drawdown Max | -1.8% | -5.3% | -7.4% | - | -12.2% |
This is a marketing communication. Past performance is no guarantee of future performance. The investment presents a risk of capital loss. Before any investment, please refer to the risks and various costs of each share class available in the prospectus and the KIDs.
Performances since inception in %
January | February | March | April | May | June | July | August | September | October | November | December | Ytd Perf% | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -0.56% | 0.83% | 2.80% | -0.70% | 0.68% | 0.34% | -1.04% | 1.09% | 0.28% | -0.05% | -0.86% | 2.80% | |
2023 | -1.83% | -1.55% | 0.76% | -0.16% | -0.38% | 0.95% | -0.84% | -0.18% | -0.58% | 2.50% | -0.91% | 0.23% | -2.04% |
2022 | -1.54% | 0.35% | 2.16% | -0.68% | -1.15% | 1.94% | 0.98% | 0.90% | 0.05% | 0.86% | -0.43% | -0.03% | 3.39% |
2021 | 1.24% | 0.81% | 3.20% | 1.67% | 2.35% | -0.91% | 1.67% | -1.42% | 1.87% | 0.06% | -0.69% | 1.83% | 12.21% |
2020 | 1.31% | -1.00% | -1.18% | 0.92% | 0.27% | -0.67% | 0.62% | -1.31% | 0.08% | -1.48% | -1.83% | -1.30% | -5.48% |
2019 | 2.34% | 1.41% | 0.41% | -1.65% | 0.16% | -0.10% | 0.04% | -0.64% | -0.59% | -0.50% | 1.33% | -1.12% | 1.02% |
2018 | 0.78% | -1.54% | -0.35% | 1.12% | 0.11% | -1.83% | 0.26% | 0.19% | 0.06% | -2.18% | -3.10% | -0.45% | -6.81% |
2017 | 0.56% | 0.88% | -0.33% | 1.66% | 2.79% |
This is a marketing communication. Past performance is no guarantee of future performance. The investment presents a risk of capital loss. Before any investment, please refer to the risks and various costs of each share class available in the prospectus and the KIDs.
Information elements
Inception | 22/09/2017 |
---|---|
Legal status | SICAV - UCITS |
Volatility target | 5% - 7% |
Recommended investment period | 5 years |
Liquidity / NAV | Weekly |
Deadline | Thursday before 5 pm CET |
Senior Manager | Olivier Leymarie |
Code ISIN | LU1685858703 |
Code Bloomberg | HEALAEC LX |
SFDR | Article 8 |
Base currency | EUR |
---|---|
Domicile | Luxembourg |
Administrator | CACEIS Bank Luxembourg |
Auditor | Deloitte & Touche |
Minimum initial subscription | EUR 50 000 |
Management fees | 1.50% |
Performance fees | 20% High Water Mark |
Hurdle | ESTR |
Assignment result | Capitalization |